Trial
NCT05018936
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Peking Union Medical College Hospital
Collaborators
—
Condition
Aplastic Anemia
Intervention
Hetrombopag
Why stopped
The ethical application for the institution was not completed, and the research was not carried out.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-08